Neuromyelitis Optica: all 178 studies
Page 2 of 2. Open to participants first (78), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of the Impact of Multiple Sclerosis and Its Treatments on Women FertilityCompletedNCT07164924
- Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum DisorderCompletedNCT07032337
- Meningococcal Vaccination in Patients on Complement InhibitorsActive, not recruitingNCT06906692
- BLAZE-Limiting Approach in NMOSDCompletedNCT06888622
- Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSDActive, not recruitingNCT06724809Phase 3
- Eculizumab For Acute Attack of Neuromyelitis Optica Spectrum DisorderWithdrawnNCT06673394Phase 2
- A Study of RD06-04 in Patients With Active Autoimmune DiseasesWithdrawnNCT06548620Early Phase 1
- Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)Active, not recruitingNCT06180278Phase 4
- A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum DisordersWithdrawnNCT05974293Phase 2
- Efficacy and Safety of Ruxolitinib in Neuromyelitis Optica Spectrum DisordersWithdrawnNCT05909943Phase 1/2
- Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum DisorderCompletedNCT05896605Phase 4
- Efficacy of Electroacupuncture in NMOSD Patients With Pain: Study ProtocolCompletedNCT05871658Not applicable
- ACT with NMOSD Patients and Caregivers Pilot StudyCompletedNCT05840055Not applicable
- Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of R/R Neuromyelitis OpticaCompletedNCT05828212Phase 1
- Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum DisordersActive, not recruitingNCT05792462Phase 1
- Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders (AQUARELLE)Active, not recruitingNCT05730699Phase 3
- Restless Legs Syndrome in People With Neuromyelitis Optica Spectrum DisorderStatus unknownNCT05573711
- Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)CompletedNCT05551598Phase 2
- A Study of LP-168 in Healthy VolunteersCompletedNCT05432713Phase 1
- Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen DeterminationStatus unknownNCT05414890
- Effects of Ofatumumab Treatment on Immune Cells and Meningeal Lymphatic Drainage in Patients With Demyelinating DiseasesStatus unknownNCT05414487
- Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum DisordersActive, not recruitingNCT05403138Phase 2/3
- An Open Label Study of the Effects and Safety of Zanubrutinib in NMOSDs Adult PatientsTerminatedNCT05356858Phase 2
- Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSDActive, not recruitingNCT05346354Phase 2/3
- A Study of MIL62 in Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)Active, not recruitingNCT05314010Phase 3
- A Study of Orelabrutinib in Patients With AQP4-IgG Positive Neuromyelitis Optica Spectrum DisorderStatus unknownNCT05284175Not applicable
- Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration in Multiple Sclerosis - a Preclinical StudyStatus unknownNCT05245344
- Safety of Therapeutic Step-down in Neuromyelitis OpticaCompletedNCT05155644
- Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum DisordersCompletedNCT05154734Phase 1/2
- Lifestyle Weight Management Program: Interviews and Stakeholder Meetings.Status unknownNCT05070286
- Imaging Evaluation of Central Nervous Autoimmune DiseasesStatus unknownNCT04822623
- IA or PE - What is the Best Treatment Option of Steroid Refractory Neurological Autoimmune DiseasesCompletedNCT04687332Not applicable
- An Open Label Study of the Effects of SHR1459 in NMOSDs PatientsCompletedNCT04670770Phase 2
- In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized NMOCompletedNCT04629274Not applicable
- Association Between the Effect of Glucocorticoid Pulse Therapy on Neuromyelitis Optica (NMO) and Gene PolymorphismStatus unknownNCT04601142
- An Diagnostic Cohort on AQP4-Immunoglobulin G Detection KitCompletedNCT04388072
- Epidemiological Characteristics of COVID-19 in Patients With MS or NMOCompletedNCT04355611
- Rituximab at Low dosE for neuromyelitiS optiCa spectrUm disordEr (RESCUE)CompletedNCT04256252Phase 4
- A Study of HBM9161 in NMOSD PatientsCompletedNCT04227470Phase 1
- Immunologic Biomarker Profile of Cerebrospinal FluidCompletedNCT04202055
- A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum DisordersCompletedNCT04146285Phase 1
- Diagnosis of ON With or Without MS or NMOSDTerminatedNCT04131764
- MS and NMOSD in African-AmericansWithdrawnNCT04131673
- Treatment Response Among Chinese Neuromyelitis Optica Spectrum DisordersStatus unknownNCT04101058
- Comparison of the Efficacy and Safety of Immunoadsorption and Plasma Exchange for Acute Attack of Refractory Neuromyelitis Optica Spectrum DisordersStatus unknownNCT04064944Phase 2
- PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.CompletedNCT03942952
- Autologous Transplant To End NMO Spectrum DisorderWithdrawnNCT03829566Phase 2/3
- Clinical Patterns of Neuromyelitis Optica Spectrum Disorders in Assiut University HospitalCompletedNCT03819413
- Pediatric NMOSD Observational StudyCompletedNCT03766347
- Treatment of Relapsed and/or Refractory AQP4-IgG Seropositive NMOSD by Tandem CAR T Cells Targeting CD19 and CD20WithdrawnNCT03605238Phase 1
- Clinic Registry Study of Optic Neuromyelitis Spectrum Disease in ChinaStatus unknownNCT03514030
- Tocilizumab vs Azathioprine in Neuromyelitis Optica Spectrum DisordersCompletedNCT03350633Phase 2/3
- A Phase III Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Neuromyelitis Optica Spectrum DisordersTerminatedNCT03330418Phase 3
- Central Pain Study for ABX-1431CompletedNCT03138421Phase 1
- Pathologic-MRI Findings in Atypical IIDDCompletedNCT03121105
- A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSDCompletedNCT03062579Phase 1/2
- Efficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum DisorderCompletedNCT02893111Phase 2
- The French Multiple Sclerosis RegistryStatus unknownNCT02889965
- The French Cohort and Biobank of Devic's Neuromyelitis Optica and Related Neurological Disorders (NMOSD) (NOMADMUS)CompletedNCT02850705
- Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum DisordersStatus unknownNCT02836327
- Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese PatientsStatus unknownNCT02809079Phase 4
- A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse MyelitisTerminatedNCT02398994Phase 3
- Treatment of Multiple Sclerosis and Neuromyelitis Optica With Regulatory Dendritic Cell: Clinical Trial Phase 1 BCompletedNCT02283671Phase 1
- Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum DisordersCompletedNCT02249676Phase 2
- Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica RelapsesWithdrawnNCT02087813Phase 1
- Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum DisordersStatus unknownNCT02021825Phase 4
- Stem Cell Ophthalmology Treatment StudyStatus unknownNCT01920867Not applicable
- Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy.CompletedNCT01845584Phase 2
- The Longitudinal CONQUER Study of Rare Neuroimmunologic DisordersActive, not recruitingNCT01623076
- Maintenance Plasma Exchange for Neuromyelitis OpticaCompletedNCT01500681
- Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis OpticaStatus unknownNCT01364246Phase 1/2
- Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis OpticaTerminatedNCT01339455Phase 1/2
- Evaluation of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution OctStatus unknownNCT01024985
- Autologous Stem Cell Transplant for Neurologic Autoimmune DiseasesActive, not recruitingNCT00716066Phase 2
- Safety and Tolerability of Rituximab in Neuromyelitis OpticaCompletedNCT00501748Phase 1
- Biobank For MS And Other Demyelinating DiseasesActive, not recruitingNCT00445367
- A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)CompletedNCT00304291Phase 4
- Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous MethylprednisoloneStatus unknownNCT00004645Phase 3